VentriPoint Diagnostics (CVE:VPT) Shares Up 36.4% – Still a Buy?

VentriPoint Diagnostics Ltd. (CVE:VPT) shot up 36.4% on Saturday . The company traded as high as C$0.17 and last traded at C$0.15. 1,722,555 shares changed hands during trading, an increase of 726% from the average session volume of 208,641 shares. The stock had previously closed at C$0.11.

VentriPoint Diagnostics Trading Up 36.4%

The company has a market capitalization of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The stock has a fifty day moving average of C$0.13 and a two-hundred day moving average of C$0.12.

VentriPoint Diagnostics Company Profile

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.